From September 8, 2022 to September 30, 2022, the company has repurchased 524,542 shares, for $7.97 million. With this, the company has completed the repurchase of 524,542 shares, for $7.97 million under the buyback announced on September 8, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.99 USD | +0.20% | -1.45% | +2.32% |
2023 | Saba Capital Master Fund, Ltd Issues a Letter to BlackRock Health Sciences Term Trust | CI |
2023 | BlackRock Health Sciences Term Trust authorizes a Buyback Plan. | CI |
1st Jan change | Capi. | |
---|---|---|
+2.32% | 1.6B | |
+6.09% | 12.85B | |
+12.28% | 9.57B | |
+0.80% | 5.6B | |
+4.67% | 5.5B | |
+6.13% | 5.21B | |
+19.43% | 4.64B | |
+18.68% | 4.48B | |
+2.49% | 4.07B | |
+3.73% | 3.92B |
- Stock Market
- Equities
- BMEZ Stock
- News BlackRock Health Sciences Term Trust
- Tranche Update on BlackRock Health Sciences Trust II's Equity Buyback Plan announced on September 8, 2022.